| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | Sep 3, 2025 | Spero Therapeutics, Inc. | COO | Sell | 52.5 | -1,695 | -0.23% | ✗ | $3.3K |
| Feb 3, 2025 | Feb 5, 2025 | Spero Therapeutics, Inc. | COO | Sell | 91.3 | +209,602 | 39.41% | ✗ | $44.1K |
| Aug 27, 2024 | Aug 29, 2024 | Spero Therapeutics, Inc. | COO | Sell | 52.5 | -2,213 | -0.41% | ✗ | $3K |
| Feb 1, 2024 | Feb 5, 2024 | Spero Therapeutics, Inc. | COO | Sell | 91.3 | +208,760 | 64.18% | ✗ | $42.1K |
| Aug 28, 2023 | Aug 30, 2023 | Spero Therapeutics, Inc. | Chief Development Officer | Sell | 50.0 | -1,854 | -0.57% | ✗ | $2.3K |
| Feb 1, 2023 | Feb 3, 2023 | Spero Therapeutics, Inc. | COO | Sell | 90.0 | +262,563 | 406.56% | ✗ | $6.3K |